Nada Čikeš

541 total citations
38 papers, 328 citations indexed

About

Nada Čikeš is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Nada Čikeš has authored 38 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Nada Čikeš's work include Systemic Lupus Erythematosus Research (12 papers), Systemic Sclerosis and Related Diseases (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Nada Čikeš is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Systemic Sclerosis and Related Diseases (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Nada Čikeš collaborates with scholars based in Croatia, Austria and United States. Nada Čikeš's co-authors include Miroslav Mayer, Branimir Anić, Marko Radoš, Ivana Kolčić, Mariko Y. Momoi, Senga Whittingham, F Howard, Carol L. Williams, H. Clark Hoagland and Vanda A. Lennon and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Respiratory Journal and Mayo Clinic Proceedings.

In The Last Decade

Nada Čikeš

32 papers receiving 316 citations

Peers

Nada Čikeš

RHEUM

NEURO

PFM

IMMUN

PRM

Theodora Tsirouki Greece

Richard Stawell Australia

Stefania Tamiazzo Italy

Akiko Suda Japan

Charles Makin United States

Dimitri Peterlana Italy

Claire Masson France

Akira Hatakeyama Japan

G Bolla France

Maryam Adas United Kingdom

Theodora Tsirouki Greece

Nada Čikeš

118 ×1.0

RHEUM

34 ×0.5

NEURO

29 ×0.5

PFM

48 ×0.9

IMMUN

47 ×1.0

PRM

Citations per year, relative to Nada Čikeš Nada Čikeš (= 1×) peers Theodora Tsirouki

Countries citing papers authored by Nada Čikeš

Since Specialization

Citations

This map shows the geographic impact of Nada Čikeš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Čikeš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Čikeš more than expected).

Fields of papers citing papers by Nada Čikeš

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Čikeš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Čikeš. The network helps show where Nada Čikeš may publish in the future.

Co-authorship network of co-authors of Nada Čikeš

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Čikeš. A scholar is included among the top collaborators of Nada Čikeš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Čikeš. Nada Čikeš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Čikeš, Nada. (2022). Neuropsychiatric manifestations of Systemic Lupus Erythematosus. PubMed. 56(2). 29–33.

2.

Nikiphorou, Elena, G. Fragoulis, Annamaria Iagnocco, et al.. (2019). 2019 EULAR recommendations for the generic core competences of health professionals in rheumatology. Annals of the Rheumatic Diseases. 79(1). 53–60. 29 indexed citations

3.

Birnhuber, Anna, Slaven Crnković, Valentina Biasin, et al.. (2019). IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis. European Respiratory Journal. 54(3). 1900154–1900154. 32 indexed citations

4.

Bakula, Marija, Nada Čikeš, & Branimir Anić. (2019). Validation of the new classification criteria for systemic lupus erythematosus on a patient cohort from a national referral center: a retrospective study. Croatian Medical Journal. 60(4). 333–344. 7 indexed citations

5.

Sivera, Francisca, Sofía Ramiro, Nada Čikeš, et al.. (2016). Rheumatology training experience across Europe: analysis of core competences. Arthritis Research & Therapy. 18(1). 213–213. 15 indexed citations

6.

Katalinić, Darko, Branimir Anić, Ranka Štern-Padovan, et al.. (2011). Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine - A metastatic disease 17 Years after complete surgical resection. World Journal of Surgical Oncology. 9(1). 150–150. 8 indexed citations

7.

Novak, Srđan, et al.. (2011). Clinical significance of autoantibodies induced by infliximab treatment: two-year follow-up after infliximab discontinuation.. PubMed. 19(3). 156–60. 1 indexed citations

8.

Hojs, Radovan, Nada Čikeš, Aleš Ambrožič, et al.. (2011). Antiphospholipid antibodies and atherosclerosis: Insights from Rheumatoid arthritis – A five-year follow-up study. Immunobiology. 216(12). 1331–1337. 12 indexed citations

9.

Barešić, Marko, et al.. (2010). Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia. The Brazilian Journal of Infectious Diseases. 14(1). 92–95. 8 indexed citations

10.

Mayer, Miroslav, et al.. (2010). Antiphospholipid syndrome and central nervous system. Clinical Neurology and Neurosurgery. 112(7). 602–608. 29 indexed citations

11.

Barešić, Marko, et al.. (2010). Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia. The Brazilian Journal of Infectious Diseases. 14(1). 92–95. 6 indexed citations

12.

Čikeš, Nada, et al.. (2008). Non-MS autoimmune demyelination. Clinical Neurology and Neurosurgery. 110(9). 905–912. 40 indexed citations

13.

Čikeš, Nada. (2005). Central nervous system involvement in systemic connective tissue diseases. Clinical Neurology and Neurosurgery. 108(3). 311–317. 11 indexed citations

14.

Jelaković, Bojan, et al.. (1999). Antibodies to Tamm–Horsfall protein in endemic nephropathy. Nephrology Dialysis Transplantation. 14(11). 2645–2649. 2 indexed citations

15.

Harjaček, Miroslav, et al.. (1999). Angiotenzin converting enzyme(ACE)gene polymorphism and lupus nephritis. 67.

16.

Jelaković, Bojan, et al.. (1996). Antibodies to Tamm-Horsfall protein in patients treated with extracorporeal shock wave lithotripsy (ESWL). Clinica Chimica Acta. 256(2). 95–102. 1 indexed citations

17.

Čikeš, Nada, et al.. (1996). Binding of Anti-Double Stranded (ds) DNA-Positive Sera to Denatured (d) DNA and Synthetic Poly[dA-dT] x Poly[dA-dT] Double Stranded Copolymer in an ELISA Format. Clinical Chemistry and Laboratory Medicine (CCLM). 34(4). 343–348.

18.

Jelaković, Bojan, et al.. (1994). Antibodies to Tamm-Horsfall Protein in Patients with Acute Pyelonephritis. Clinical Chemistry and Laboratory Medicine (CCLM). 32(5). 337–340. 3 indexed citations

19.

Somogyi, László, Nada Čikeš, & Matko Marušić. (1993). Evaluation of Criteria Contributions for the Classification of Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 22(2). 58–62. 10 indexed citations

20.

Marušić, Matko, et al.. (1991). Natural killer cell number and activity in remission phase of systemic connective tissue diseases.. PubMed. 35(3). 133–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact